Anatara Lifesciences gets good news on GaRP supplement

Anatara Lifesciences (ASX:ANR) has released encouraging pre-clinical trial data of its Gastrointestinal ReProgramming (GaRP) dietary supplement which targets diarrhoea. The company is now targeting the second half of this year for human trials of GaRP which treats underlying causes such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). “Anatara believes its GaRP dietary…

Cannabis products no dope as sales tick over

Australia’s two dozen would be cannabis product manufacturers continue to score goals in the young market, with two producers announcing major milestones on the same day. Medicinal cannabis producer THC Global (ASX: THC) has received Therapeutic Goods Administration approval for its Southport manufacturing facility which has harvested its first cannabis crop and begun manufacturing operations.…

IDT begins cannabis manufacture with high-tech bong

It looks like the world’s biggest bong, but the photograph from pharmaceutical manufacture IDT Australia is strictly legit. The Melbourne company has begun manufacturing medicinal cannabis for local producer Cann Group (ASX: CAN). The first product, medicinal cannabis dried flower, were packed by IDT under GMP certified conditions and will undergo testing ahead of release…

Canberra eases Australian Made path for complementary medicines

The federal government has responded to concerns from the complementary medicine industry by making it easier for them to be sold as ‘Made in Australia’ and with the ‘Australian Made’ logo. The Government, with support from the states, has introduced an interim measure to allow access for complementary medicines that meet certain manufacturing eligibility requirements.…

First Australian medicinal cannabis produced in Queensland

THC Global Group (ASX:THC) has completed the first farm-to-pharma processing of medicinal cannabis in Australia at its Southport manufacturing facility (pictured) in Queensland. The Southport Facility is the largest pharmaceutical bio-floral extraction facility in the Southern Hemisphere and is licenced and permitted to process medicinal cannabis. THC Global CEO Ken Charteris said: “Completing this Australian…

Major project status for medicinal cannabis

The federal government has granted major project status for the development of new medicinal cannabis facilities in South East Queensland and regional Victoria. Major project status has been granted to Hydroganics for a multi-stage $333 million medicinal cannabis facility in Queensland and Canopy Growth for a $70 million facility in Victoria. Hydroganics is expected to…

Althea to expand into medicinal cannabis manufacturing

Medicinal cannabis cultivator and manufacturer Althea Global (ASX: AGH) has ended the year hitting milestones with 3,031 patients prescribed the drug by 375 healthcare professionals. Only 159 patients had been prescribed the company’s products a year ago. CEO Josh Fegan told the annual general meeting that the company also entered the United Kingdom market and…

Baxter Labs celebrates 25 years production

Melbourne pharmaceutical manufacturer Baxter Laboratories has celebrated 25 years as a manufacturer of skin care products, sunscreens and topical pharmaceutical. Staff paused to celebrate 25 years of service at the plant yesterday (below). The company offers a complete service to third parties from research and development to regulatory services, manufacturing, filling , warehousing and global…